Related topics: Materials & Formulation, Processing (automation, control, separation)
German inhaled drug specialist Aeropharm will use Prosonix’ sonocrystallisation technology to develop generics in its candidate pipeline.
The Rudolstadt-headquartered firm said that Prosonix’ unique crystallisation approach produces optimally-sized active pharmaceutical ingredient (API) particles direct from solution, bypassing destructive processes like milling and micronization that are used in traditional manufacture.
Aeropharm is targeting the lucrative inhaled drug market, which is expected to be worth $38bn in 2012. In particular the firm is focused on the development of “difficult-to-make” generic products.
Copyright - Unless otherwise stated all contents of this web site are © 2000/2009 - Decision News Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department: Administration & Finance - Full details for the use of materials on this site can be found in the Terms & Conditions
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
© 2000/2009 - Decision News Media SAS - All right reserved.
